S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
Log in
CNSX:PLUS

ePlus Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.57
MA: $0.74
$1.01
52-Week Range N/A
Volume20,900 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Plus Products Inc. develops, manufactures, and sells cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company sells products under the PLUS brand to dispensaries and delivery service customers. Plus Products Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Headlines

Plus Products misses on revenue
August 20, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceuticals: Other
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1 213.282.6987
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

MarketRank

Overall MarketRank

0.58 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive PLUS News and Ratings via Email

Sign-up to receive the latest news and ratings for PLUS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ePlus (CNSX:PLUS) Frequently Asked Questions

What stocks does MarketBeat like better than ePlus?

Wall Street analysts have given ePlus a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ePlus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are ePlus' key executives?

ePlus' management team includes the following people:
  • Mr. Craig F. Heimark, Chairman, Chief Strategy Officer & Sec. (Age 65, Pay $386.29k)
  • Mr. Jacob F. Heimark, Co-Founder, CEO & Director
  • Ms. Jennifer Tung, Chief Risk Officer
  • Mr. Justin Gwin, Co-Founder & Head of R&D
  • Ms. Lucie Herold, Co-Founder & Head of Sales
  • Mr. Nate Pearson, Chief Financial Officer
  • Dr. Ari Mackler, Chief Scientific Officer
  • Mr. Blake Brennan, Head of Investor Relations

Who are some of ePlus' key competitors?

What other stocks do shareholders of ePlus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ePlus investors own include Co-Diagnostics (CODX), Actinium Pharmaceuticals (ATNM), Curaleaf (CURLF), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aphria (APHA), Digital Ally (DGLY), iBio (IBIO), PharmaCyte Biotech (PMCB) and T2 Biosystems (TTOO).

What is ePlus' stock symbol?

ePlus trades on the CNSX under the ticker symbol "PLUS."

How do I buy shares of ePlus?

Shares of PLUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ePlus' official website?

The official website for ePlus is www.plusproductsinc.com.

How can I contact ePlus?

The company can be reached via phone at +1 213.282.6987 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.